Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis

The use of immunobiological agents for the treatment of autoimmune diseases is increasing in medical practice. Anti-TNF therapies have been increasingly used in refractory autoimmune diseases, especially rheumatoid arthritis, with promising results. However, the use of such therapies has been associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Dias, Olívia Meira, Pereira, Daniel Antunes Silva, Baldi, Bruno Guedes, Costa, André Nathan, Athanazio, Rodrigo Abensur, Kairalla, Ronaldo Adib, Carvalho, Carlos Roberto Ribeiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075924/
https://www.ncbi.nlm.nih.gov/pubmed/24626274
http://dx.doi.org/10.1590/S1806-37132014000100012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075924/
https://www.ncbi.nlm.nih.gov/pubmed/24626274
http://dx.doi.org/10.1590/S1806-37132014000100012

Ejemplares similares